恒瑞医药(01276.HK)：HRS-8364片获得临床试验批准通知书

Core Viewpoint - Heng Rui Medicine (01276.HK) has received approval from the National Medical Products Administration for the clinical trial of HRS-8364 tablets, which will commence shortly [1] Group 1 - The company has announced the approval of a clinical trial for HRS-8364 tablets [1] - The clinical trial is expected to start in the near future [1]